U.S. Physical Therapy, Inc. (USPH) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services.
Total Revenue Chart for U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc. (USPH) revenue for FY2025 was USD 781.0M, a 16.3% change from FY2024. U.S. Physical Therapy, Inc.'s revenue grew from USD 600.0K in 1991 to USD 781.0M in 2025 (130065.0% over 34 years). Earnings per share grew from USD 0.35 in 2000 to USD 2.25 in 2022 (545.8%). Revenue compound annual growth rate: 5-year CAGR of 13.0%, 10-year CAGR of 9.0%, 20-year CAGR of 9.3%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $1.28B
- Implied Share Price
- $85.71
- Enterprise Value
- $1.60B
- Revenue (TTM)
- $804.27M
- EBITDA
- $102.01M
- Profit Margin
- 4.01%
- Trailing P/E
- 476.17
- Forward P/E
- 27.25
- Price/Book (MRQ)
- 2.77
- Price/Sales (TTM)
- 1.59
- EV/EBITDA
- 15.92
- EV/Revenue
- 1.97
- Dividend Yield
- 2.12%
- Book Value
- $30.06
- Free Cash Flow (FY2025)
- $60.99M
- Free Cash Flow Yield
- 4.77%
Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.